Have you been playing Connections, the super fun word game from the New York Times that has people sharing those multi-colored squares on social media like they did with Wordle? It’s pretty fun and ...

Australia’s prime minister announced a national buy-back plan for firearms to “get more guns off our streets” in the wake of the Bondi Beach massacre. At least 15 people were killed when two gunmen ...

Jumble has been entertaining folks since 1954 and has been a classic game where scrambled words require you to unscramble them in order to find key letters that leads to a final word to be unscrambled ...

Ford on Monday said it is pulling back on its electric vehicle plans, a move that will result in a $19.5 billion charge against its earnings to be taken mostly in the current quarter. But excluding ...

Chinese wafer manufacturer Gokin Solar has introduced a new back-contact (BC) solar module series at its Global BC Eco Summit in Guangzhou, China. The series includes three products: the GK-3-54HGFb ...

The popular theory that Stranger Things will ultimately include time travel is not new; it certainly didn’t originate with Stranger Things 5. Show producer and director Shawn Levy said the show would ...

Nineteen years is a long time to go without releasing an album. Voxtrot will close that gap this February with Dreamers In Exile, their first proper LP of new material since their 2007 self-titled ...

On Monday, Anthropic announced Opus 4.5, the latest version of its flagship model. It’s the last of Anthropic’s 4.5 series of models to be released, following the launch of Sonnet 4.5 in September and ...

The biggest stories of the day delivered to your inbox.

I’ve been pouring over the handful of reviews of Metroid Prime 4: Beyond as the embargo apparently lifts ahead of the game’s long-awaited December 2025 launch, and it’s mostly stuff you’d expect. One ...

To receive these posts by email each Monday, sign up. For more commentary on this week's readings, see the Reflections on the Lectionary page. For full-text access to all articles, subscribe to the ...

UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding phase 1 data for the bladder cancer drug didn’t reach the benchmark for further development. New Jersey-based UroGen forked ...